Using a combination of different in vivo and in vitro assays, we demonstrated that SLC35B4 expression was increased in prostate cancer tissues and that silencing SLC35B4 expression suppressed cancer cell proliferation, migration and invasion. The gene discussed is SLC35B4; the disease is prostate cancer.